These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23489308)

  • 1. Magnetic resonance imaging of the liver: a review.
    Herédia V; Altun E; Ramalho M; Semelka RC
    Expert Opin Med Diagn; 2007 Oct; 1(2):213-23. PubMed ID: 23489308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion and perfusion imaging of the liver.
    Chandarana H; Taouli B
    Eur J Radiol; 2010 Dec; 76(3):348-58. PubMed ID: 20399054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast agents in magnetic resonance imaging of the liver: present and future.
    Clément O; Siauve N; Lewin M; de Kerviler E; Cuénod CA; Frija G
    Biomed Pharmacother; 1998; 52(2):51-8. PubMed ID: 9755795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease.
    Tsurusaki M; Semelka RC; Zapparoli M; Elias J; Altun E; Pamuklar E; Sugimura K
    Eur J Radiol; 2009 Nov; 72(2):314-20. PubMed ID: 18789840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of the liver.
    Larson RE; Semelka RC
    Top Magn Reson Imaging; 1995; 7(2):71-81. PubMed ID: 7772372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of diseases of the liver and biliary system.
    Kanzer GK; Weinreb JC
    Radiol Clin North Am; 1991 Nov; 29(6):1259-84. PubMed ID: 1947045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches.
    Sommer WH; Sourbron S; Huppertz A; Ingrisch M; Reiser MF; Zech CJ
    Abdom Imaging; 2012 Apr; 37(2):164-79. PubMed ID: 21516381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.
    Schmidt GP; Wintersperger B; Graser A; Baur-Melnyk A; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Jun; 42(6):449-59. PubMed ID: 17507818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.
    Maniam S; Szklaruk J
    World J Radiol; 2010 Aug; 2(8):309-22. PubMed ID: 21160685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water excitation MPRAGE: an alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla MRI.
    Altun E; Semelka RC; Dale BM; Elias J
    J Magn Reson Imaging; 2008 May; 27(5):1146-54. PubMed ID: 18425826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of benign focal liver lesions.
    Ba-Ssalamah A; Baroud S; Bastati N; Qayyum A
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):403-19, ix. PubMed ID: 21094447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative comparison of 3-T and 1.5-T MRI in the evaluation of epilepsy.
    Phal PM; Usmanov A; Nesbit GM; Anderson JC; Spencer D; Wang P; Helwig JA; Roberts C; Hamilton BE
    AJR Am J Roentgenol; 2008 Sep; 191(3):890-5. PubMed ID: 18716125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
    Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
    Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MRI and liver metastases.
    Chandarana H; Taouli B
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):451-64, x. PubMed ID: 21094449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of magnetic resonance tomography in the detection and differential diagnosis of focal liver lesions].
    Hamm B
    Radiologe; 1992 May; 32(5):232-40. PubMed ID: 1635983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.